Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04925427 · ClinicalTrials.gov registry record · NA
Reducing Opioid Mortality in Illinois
A NA study of Opioid Use Disorder and Opioid Use, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 5
- Study locations
NCT04925427: Recruiting NA study of Opioid Use Disorder and Opioid Use, sponsored by University of Chicago.
NCT04925427 is a NA study of Opioid Use Disorder and Opioid Use that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,500 participants, below the 4,650-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (68% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04925427, a NA study of Opioid Use Disorder and Opioid Use, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 5
- Study locations
Study Summary
Reducing Opioid Mortality in Illinois (ROMI) is 5-year research study led by the University of Chicago in partnership with the University of Illinois at Chicago's (UIC) Community Outreach Intervention Projects (COIP), the Illinois Criminal Justice Information Authority (ICJIA) and the American Institutes for Research (AIR). ROMI aims to understand and test strategies for linking individuals with a history of opioid use disorder who are released from Illinois jails and prisons to substance use treatment. ROMI is one of twelve grants awarded by the National Institutes of Health (NIH) as part of the Justice Community Opioid Innovation Network (JCOIN) to support research on quality addiction treatment for opioid use disorder in criminal justice settings nationwide.
Conditions Studied
Interventions
- BEHAVIORAL Case Management and Peer Recovery
- BEHAVIORAL Naloxone-Only
Study Locations (5)
Illinois
- Cook County Department of Corrections - Chicago
- Jackson County Jail - Murphysboro
- LaSalle County Jail - Ottawa
- Illinois Department of Corrections - Springfield
- Lake County Sheriff's Office Corrections Division - Waukegan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2021-08-10 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
What NCT04925427 shows while recruiting
NCT04925427 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, below the 4,650-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (68% lower).
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Case Management and Peer Recovery is the first listed.
NCT04925427 lists 5 locations in 1 state (Illinois).
Frequently Asked Questions
What is clinical trial NCT04925427 about?
NCT04925427 is a clinical study titled "Reducing Opioid Mortality in Illinois". Reducing Opioid Mortality in Illinois (ROMI) is 5-year research study led by the University of Chicago in partnership with the University of Illinois at Chicago's (UIC) Community Outreach Intervention Projects (COIP), the Illinois Criminal Justice Information Authority (ICJIA) and the American Insti...
What is the current status of trial NCT04925427?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2021-08-10. Estimated completion is 2026-08-30.
What conditions does trial NCT04925427 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use.
What interventions are being tested in trial NCT04925427?
The interventions under investigation include: Case Management and Peer Recovery (BEHAVIORAL), Naloxone-Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT04925427?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04925427 being conducted?
This trial has 5 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04925427's enrollment target sits among peer trials
1,500 14th of 257 higher than 244 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI